Glaxo in bid for Pfizer's Listerine business
GlaxoSmithKline was today at the centre of speculation linking it to an €11.6bn bid for Pfizer’s Listerine-to-Sudafed consumer healthcare arm.
Such a move would transform Glaxo into the world’s biggest maker of non-prescription drugs, as well as the second largest prescription drugs supplier.
The Business Hub
Newsletter
News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.





